Monday, October 18, 2021

Merck's COVID-19 Pill Effective Against Variants

{{my.Email-Subject}}
 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 

Laboratory studies show Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta. read more ]

Pfizer COVID-19 Vaccine Safe for Kids Ages 5-7 Years

A smaller dose of the Pfizer-BioNTech's COVID-19 vaccine is safe and generates a robust immune response in a clinical trial of kids ages 5 years to 11 years, according to researchers. read more ]

FDA Amends EUA to Allow Pfizer's COVID-19 Booster Vaccine

The U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to allow for a single booster dose to be administered at least six months after completion of the primary series in individuals 65 years of age and older; individuals 18 through 64 years of age at high risk of severe COVID-19; and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19, including severe COVID-19. read more ]

Severe COVID-19 May Cause Autoimmune Disease

A new study reveals patients who have been hospitalized with severe COVID-19 might be more likely to harbor self-attacking antibodies and may eventually suffer from a full-blown autoimmune disease. read more ]

Industry News

Industry News Image

From CSL Behring

As a precautionary measure, CSL Behring is voluntarily withdrawing one lot of Privigen 10% (intravenous immune globulin [human]) due to an increased frequency of reports of hypersensitivity reactions during or after administration. The lot number being withdrawn is P100287723 with an expiry date of Nov. 17, 2023, NDC number 44206-0437-10. read more ]

From Johnson & Johnson

In a late-stage clinical trial, Johnson & Johnson's Ebola two-dose vaccine regimen was well-tolerated and induced antibody responses to the Zaire ebolavirus species 21 days after the second dose in 98 percent of all participants. read more ]

From AstraZeneca

AstraZeneca, which developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency authorization for COVID-19 prevention. read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Days On Hand
     
 
 
 
     
Grifols Albumin

What's New at FFF

PYRIMETHAMINE TABLETS  (ALVOGEN)

PYRIMETHAMINE TABLETS 25 mg are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. They are supplied as white, round, biconvex, scored tablets debossed on one side with "F" above the score line and "26" below the score line, each containing 25 mg pyrimethamine in bottles of 100 (NDC 47781-925-01) and 30 (NDC 47781-925-30) and in 30-count unit-dose blister cartons (NDC 47781-925-31).

For more information about PYRIMETHAMINE TABLETS, log in to biosupply.fffenterprises.com

ROCURONIUM BROMIDE  (ALMAJECT INC.)

ROCURONIUM BROMIDE injection is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is supplied 50 mg/5 mL and 100mg/10 mL multiple-dose vials in cartons of 10.

For more information about ROCURONIUM BROMIDE, view FFF's Rapid Commit Program www.fffenterprises.com/rapid-commit/index.html

KETOROLAC TROMETHAMINE  (ALMAJECT INC.)

KETOROLAC TROMETHAMINE is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. It is supplied in 15 mg/mL, 1 mL; 30 mg/mL, 1 mL; and 60 mg/2 mL single-dose vials in cartons of 25.

For more information about KETOROLAC TROMETHAMINE, view FFF's Rapid Commit Program www.fffenterprises.com/rapid-commit/index.html

PREVNAR 20  (WYETH PHARMACEUTICALS)

PREVNAR 20 (pneumococcal 20-valent conjugate vaccine), suspension for intramuscular injection is indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older. It is supplied in single-dose prefilled syringes in a package of 1 or 10.

For more information about PREVNAR 20, log in to biosupply.fffenterprises.com

ACETAMINOPHEN INJECTION  (B. BRAUN MEDICAL)

ACETAMINOPHEN INJECTION is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older; management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older; and reduction of fever in adult and pediatric patients. It is a clear colorless solution supplied sterile and nonpyrogenic in 50 mL and 100 mL fill PAB containers packaged 24 per case.

For more information about ACETAMINOPHEN INJECTION, log in to biosupply.fffenterprises.com

VAXELIS  (SANOFI PASTEUR)

VAXELIS is a three-dose vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years old. It is supplied in a single-dose vial in packages of 10 and a 0.5 mL single-dose prefilled syringe with a Luer lock connection and a tip cap without a needle in packages of 10.

For more information about VAXELIS, log in to biosupply.fffenterprises.com

CLOBEX  (GALDERMA LABORATORIES)

CLOBEX (clobetasol propionate) shampoo 0.05% is a corticosteroid indicated for the treatment of moderate to severe scalp psoriasis in subjects 18 years and older. It is supplied as a translucent, colorless to pale yellow viscous liquid in a 4-ounce bottle.

For more information about CLOBEX, log in to biosupply.fffenterprises.com

DIFFERIN GEL  (GALDERMA LABORATORIES)

DIFFERIN gel 0.3% is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years and older. It is supplied in 15 g and 45 g tubes and a 45 g pump.

For more information about DIFFERIN GEL, log in to biosupply.fffenterprises.com

DIFFERIN LOTION  (GALDERMA LABORATORIES)

DIFFERIN lotion 0.1% is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years and older. It is supplied as a white to off-white liquid in a 2-ounce bottle equipped with a lotion-dispensing pump.

For more information about DIFFERIN LOTION, log in to biosupply.fffenterprises.com

MIRVASO  (GALDERMA LABORATORIES)

MIRVASO (brimonidine) topical gel 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years and older. It is supplied as a whit to light yellow opaque gel in a laminated tube or pump with a child-resistant cap in 30 g and 45 g tubes and a 30 g pump.

For more information about MIRVASO, log in to biosupply.fffenterprises.com

VECTICAL OINTMENT  (GALDERMA LABORATORIES)

VECTICAL ointment is a vitamin D analog indicated for the topical treatment of mild to moderate plaque psoriasis in adult and pediatric patients 2 years and older. It is supplied in a 100 g collapsible aluminum tube.

For more information about VECTICAL OINTMENT, log in to biosupply.fffenterprises.com

EPIDUO FORTE  (GALDERMA LABORATORIES)

EPIDUO FORTE gel 0.3%/2.5% is a combination of adapalene (a retinoid) and benzoyl peroxide indicated for the topic treatment of acne vulgaris. It is supplied as a white to very pale yellow and opaque gel in 15 g, 30 g, 45 g, 60 g and 70 g pumps.

For more information about EPIDUO FORTE, log in to biosupply.fffenterprises.com

ORACEA  (GALDERMA LABORATORIES)

ORACEA is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. It is supplied in an amount equivalent to 40 mg in a bottle of 30.

For more information about ORACEA, log in to biosupply.fffenterprises.com

SOOLANTRA CREAM  (GALDERMA LABORATORIES)

SOOLANTRA cream 1% is indicated for the treatment of inflammatory lesions of rosacea. It is supplied as a white to pale yellow cream in a laminated tube with a child-resistant cap in 30 g, 45 g and 60 g tubes.

For more information about SOOLANTRA CREAM, log in to biosupply.fffenterprises.com

AKLIEF CREAM  (GALDERMA LABORATORIES)

AKLIEF cream 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years and older. It is supplied as a white cream in 30 g, 45 g and 75 g pumps.

For more information about AKLIEF CREAM, log in to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective October 1, 2021, through December 31, 2021.

 
Calculate Your Current Medicare IVIG/SCIG Rates
Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
IVIG
ASCENIV J1554 $963.54 $948.09
BIVIGAM J1556 $140.89 $138.72
FLEBOGAMMA J1572 $73.61 $72.43
GAMMAGARD SD J1566 $130.98 $128.88
GAMMAPLEX J1557 $97.06 $95.50
OCTAGAM J1568 $83.26 $81.92
PANZYGA 90283 / J1599 ** **
PRIVIGEN J1459 $88.96 $87.53
SCIG
CUTAQUIG 90284 / J3590 ** **
CUVITRU J1555 $144.96 $142.64
HIZENTRA J1559 $115.82 $113.96
HYQVIA J1575 $151.55 $149.12
XEMBIFY J1558 $136.05 $133.87
IVIG / SCIG
GAMMAGARD LIQUID J1569 $88.98 $87.55
GAMMAKED J1561 $96.44 $94.89
GAMUNEX-C J1561 $96.44 $94.89

* Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.
** ASP-based Medicare payment rate not yet available; payment rate assigned by your Medicare Administrative Contractor.

 

Resources

FFF customers may order the following complementary resources to help you with your practice:

•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Home | About | Advertise | Subscribe | Contact – © FFF Enterprises, Inc.